Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DDI Study of MLC1501 with CYP and Transporter Probes
NCT04233437Phase 1Completed
- Sponsor
- Moleac
- Start
- Feb 2020
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of MLC1501 in stroke (2 cohorts), sponsored by Moleac. Primary endpoints: Area Under Curve at 18 days, Maximum Concentration at 18 days and 1 more. Started Feb 2020; status: completed.
02
Drugs
MLC1501
03
Conditions
stroke
Beyond the preview
Go deeper on NCT04233437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04233437.